JP2025502242A5 - - Google Patents

Info

Publication number
JP2025502242A5
JP2025502242A5 JP2024541925A JP2024541925A JP2025502242A5 JP 2025502242 A5 JP2025502242 A5 JP 2025502242A5 JP 2024541925 A JP2024541925 A JP 2024541925A JP 2024541925 A JP2024541925 A JP 2024541925A JP 2025502242 A5 JP2025502242 A5 JP 2025502242A5
Authority
JP
Japan
Prior art keywords
composition
composition according
administered
pharmaceutically acceptable
acceptable salt
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024541925A
Other languages
English (en)
Japanese (ja)
Other versions
JP2025502242A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2023/061202 external-priority patent/WO2023147318A2/en
Publication of JP2025502242A publication Critical patent/JP2025502242A/ja
Publication of JP2025502242A5 publication Critical patent/JP2025502242A5/ja
Pending legal-status Critical Current

Links

JP2024541925A 2022-01-25 2023-01-25 水性セビメリン組成物および使用方法 Pending JP2025502242A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
USPCT/US2022/013586 2022-01-25
US2022013586 2022-01-25
PCT/US2023/061202 WO2023147318A2 (en) 2022-01-25 2023-01-25 Aqueous cevimeline compositions and methods of use

Publications (2)

Publication Number Publication Date
JP2025502242A JP2025502242A (ja) 2025-01-24
JP2025502242A5 true JP2025502242A5 (https=) 2026-02-02

Family

ID=87472506

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024541925A Pending JP2025502242A (ja) 2022-01-25 2023-01-25 水性セビメリン組成物および使用方法

Country Status (3)

Country Link
EP (1) EP4469047A4 (https=)
JP (1) JP2025502242A (https=)
WO (1) WO2023147318A2 (https=)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9034830B2 (en) * 2009-10-30 2015-05-19 Intratus, Inc. Methods and compositions for sustained delivery of drugs
AU2019214557A1 (en) * 2018-02-05 2020-08-20 Cellixbio Private Limited Combination of an antimuscarinic or an anticholinergic agent and lipoic acid and uses thereof
WO2020072971A1 (en) * 2018-10-06 2020-04-09 Biotheravision Llc Ophthalmic preparations of muscarinic agonist and methods of use
US10836760B2 (en) * 2018-10-10 2020-11-17 Presbyopia Therapies Llc Compositions and methods for the treatment of presbyopia

Similar Documents

Publication Publication Date Title
KR101147046B1 (ko) 시너지성의 2개의 폴리머 배합물을 포함하는 안과용 조성물
JP2025142338A5 (https=)
JP5161950B2 (ja) ３種のポリマーの相乗作用的組み合わせを含む眼科用組成物
JP2020196718A5 (https=)
JP2006516032A5 (https=)
CN102170863B (zh) 类粘液状组合物及其应用
JP2007500244A5 (https=)
JP6683622B2 (ja) 眼科用水性組成物
JPH05213757A (ja) 水性液剤
CN110869023A (zh) 原位凝胶形成药物组合物及其在鼻窦疾病中的应用
JP2019104727A (ja) 水溶性高分子を含む水性液剤
WO2015176655A1 (zh) 一种阿利沙坦酯固体分散体及药物组合物
JP2005529175A (ja) 第四級化アンモニウムシクロデキストリン化合物
KR102872122B1 (ko) 다회-사용 토라세미드 조성물
JP2025502242A5 (https=)
WO2014135123A1 (zh) 17α-乙炔基雄甾-5-烯-3β, 7β, 17β-三醇眼用制剂
JPH01294633A (ja) 点眼剤
CN102497854A (zh) 含有作为防腐剂的丙酸衍生物的眼用液体药物组合物
WO2024180453A1 (en) Dissolvable polymeric eye inserts with a non-ionic cellulose derivative
TR2022007382A2 (tr) Nonsteroi̇dal anti̇enflamatuvar etken madde i̇çeren göz damlasi bi̇leşi̇mi̇
KR102268319B1 (ko) 지속성 점안제 조성물
CN111643448A (zh) 一种盐酸莫西沙星眼用凝胶剂及其制备方法
CN100563657C (zh) 依诺沙星眼用缓释凝胶剂及其制备方法
JP6571391B2 (ja) 水性製剤
JP2024521460A5 (https=)